Do You Know Your Baby Has Drug Allergy Reaction?
Most of genetic disorders may not cause the newborn with severe defects or immediate damages. However, these genetic disorders could be reasons of diseases occurred during newborns development which even lead infants to sudden death.
According to the statistics, about 70% birth defects can be treated or be relieved from severe symptoms through screening and diagnoses at early stage for prompt healthcare and treatment.
With Newborn genetic screening, neonatal genetic disorders can be identified earlier. Through early intervention and better healthcare for infants, related diseases and adverse effects can be prevented and relieved.
• All Newborns
SOFIVA Baby Scan is based on Next Generation Sequencing (NGS) technology, screening genes related to multiple categories of disease at once.
SOFIVA Baby Scan can assist in identifying genetic abnormalities of related disorders and drug hypersensitivity reaction for infants or newborns without obvious symptom. Meanwhile, it also provides auxiliary aids to diagnosis for newborns identified with disorders from newborn screening.
For infants with onset symptoms, the causes of disease can be determined and early intervention can be provided through SOFIVA Baby Scan.
For more gene information, please check:
1. Physicians/ Nurses explain procedures and contents
2. Fill out consent form and collect blood samples from newborns’ heel prick
3. Sample delivered to SOFIVA Genomics
4. Processing and data analysis
5. Report completed in 10-15 working days
■ What is the gene related to Drug Hypersensitivity Reaction (DHR)?
Several genetic disorders may cause newborns with drug hypersensitivity reaction to specific drugs. These severe reactions may lead to Malignant hyperthermia or Steven-Johnson syndrome.
SOFIVA Baby Scan included genes related to medication to epilepsy, aspirin, antibiotics, anesthesia which enable to prevent adverse drug hypersensitive reaction from using relative medicine.